Pure Global
NCT05022537

Clinical Outcomes of Percutaneous Nephrolithotomy Following Retrograde Percutaneous Nephrostomy Access Using Novel Device in Comparison to Antegrade Access

The University of Texas Health Science Center, Houston·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Kidney Stone
Drug/Device/Intervention
retrograde nephrostomy
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
The University of Texas Health Science Center, Houston
Location
Houston, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2021
End date
Dec 01, 2023
Enrollment
50 participants
Primary outcome

Treatment efficacy as measured by the time taken from diagnosis to nephrostomy access,Treatment efficacy as measured by total time of access operation.,Treatment efficacy as measured by total time of access operation fluoroscopy,Treatment efficacy as measured by total time of lithotomy operation,Treatment efficacy as measured by total time of lithotomy operation fluoroscopy,Treatment efficacy as measured by length of post-operative hospital stay,Number of patients that are stone free,Number of patients with symptom free survival as defined as lack of flank pain,Number of patients with symptom free survival as defined as lack of presence of urinary or gastrointestinal symptoms,,Number of patients with symptom free survival as defined as lack of limitations to work,Number of patients with symptom free survival as defined as lack of limitations to social or daily activities.

Summary

The purpose of this study is to compare relevant clinical outcomes in patients requiring
 percutaneous nephrostomy for urolithiasis treatment between those who undergo an antegrade
 approach versus a retrograde approach and to determine which clinical characteristics predict
 success of lithotomy with anterograde or retrograde percutaneous nephrostomy approaches.

ICD-10 classifications
Kidney dialysisSmall kidney, unspecifiedDisorder of kidney and ureter, unspecifiedInjury of kidneyUnspecified kidney failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05022537
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05022537 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Texas Health Science Center, Houston and is currently Not yet recruiting. The study focuses on Kidney Stone. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.